FDA Inspection
Jubilant DraxImage Radiopharmacies Inc. dba Jubilant RadiopharmaJubilant DraxImage Radiopharmacies Inc. dba Jubilant Radiopharma – FDA Inspection, Mar 13, 2024
Record Details
This FDA Inspection record concerns Jubilant DraxImage Radiopharmacies Inc. dba Jubilant Radiopharma, with an inspection on March 13, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 13, 2024
- Product Type
- Drugs
View Company Profile
ID · 65321b70-8402-4fd8-903b-351042cbe90f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1232771
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- State Referral Letter
FDA Citations
12- Media fills, failure
- Lack of/inadequate, environmental monitoring
- Personnel, blocked or disrupted first air
- Aseptic processing outside ISO 5 area
- Inadequate smoke studies
- Non-sterile disinfecting agents, ISO 5 area/classified areas
- FDCA 501(a)(2)(A)Aseptic processing outside ISO 5 area
- FDCA 501(a)(2)(A)Inadequate smoke studies
- FDCA 501(a)(2)(A)Lack of/inadequate, environmental monitoring
- FDCA 501(a)(2)(A)Media fills, failure
Showing 10 of 12 citations.
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.